NCT04752475View on ClinicalTrials.gov

Lasix for the Prevention of De Novo Postpartum Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

April 18, 2022

Study Completion Date

May 28, 2022

Conditions
Postpartum Pregnancy-Induced HypertensionPostpartum PreeclampsiaHypertension, Pregnancy-InducedHypertension
Interventions
DRUG

Furosemide

Furosemide 20 mg pill taken daily for 5 days

OTHER

Placebo

Identical-appearing placebo pill taken daily for 5 days

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT04752475 - Lasix for the Prevention of De Novo Postpartum Hypertension | Biotech Hunter | Biotech Hunter